Dear All/Professors/Colleagues

Recently, I submitted a commentary to OSF-preprints/researchgate preprints entitled: "Is the “respiratory stimulant, Acetazolamide” add-on therapy suitable to relieve mild respiratory insufficiency in stable COVID-19 out/inpatients?"

Preprint Is the "respiratory stimulant, Acetazolamide" add-on therapy...

Please visit: https://osf.io/t5x73/

Please give me your invaluable comments/instructions, in this regard.

More Reza Khodarahmi's questions See All
Similar questions and discussions